Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126760962 | 12676096 | 2 | F | 201605 | 20160927 | 20160823 | 20160929 | EXP | PHHY2016BR114429 | NOVARTIS | 89.98 | YR | F | Y | 62.00000 | KG | 20160929 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126760962 | 12676096 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 4.6 MG, QD PATCH 5 (CM2) | N | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | ||||||
| 126760962 | 12676096 | 2 | SS | EXELON | RIVASTIGMINE TARTRATE | 1 | Oral | 1.5 MG, BID | N | 0 | 1.5 | MG | ORAL SOLUTION | BID | |||||
| 126760962 | 12676096 | 3 | SS | EXELON | RIVASTIGMINE TARTRATE | 1 | Oral | 3 MG, BID | U | 0 | 3 | MG | TABLET | BID | |||||
| 126760962 | 12676096 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 8 MG, QD | U | 0 | 8 | MG | TABLET | QD | |||||
| 126760962 | 12676096 | 5 | C | ALOIS | MEMANTINE | 1 | Oral | 20 MG, BID | U | 0 | 20 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126760962 | 12676096 | 1 | Dementia Alzheimer's type |
| 126760962 | 12676096 | 2 | Dementia Alzheimer's type |
| 126760962 | 12676096 | 3 | Dementia Alzheimer's type |
| 126760962 | 12676096 | 4 | Prophylaxis |
| 126760962 | 12676096 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126760962 | 12676096 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126760962 | 12676096 | Application site discolouration | |
| 126760962 | 12676096 | Application site hypersensitivity | |
| 126760962 | 12676096 | Body height decreased | |
| 126760962 | 12676096 | Drug administration error | |
| 126760962 | 12676096 | Hypersensitivity | |
| 126760962 | 12676096 | Macular degeneration | |
| 126760962 | 12676096 | Product adhesion issue | |
| 126760962 | 12676096 | Visual impairment | |
| 126760962 | 12676096 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |